ESLA
Estrella Immunopharma Inc.
0.429$
-2.5%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 47.1% | 100.0% | 100.0% | 59.8% | 52.2% | 38.6% | 49.7% | 57.4% | 52.8% | 59.0% | 100.0% | |
| 80.9% | 95.8% | 54.8% | 93.5% | 48.1% | 29.2% | 17.2% | 44.2% | 46.2% | 43.6% | 52.7% | 8.0% | |
| 80.9% | 95.8% | 54.8% | 93.5% | 48.1% | 29.2% | 17.2% | 44.2% | 46.2% | 43.6% | 52.7% | 8.0% | |
| – | 3.1% | 4.7% | 6.5% | 11.7% | – | 21.4% | 5.5% | 11.3% | – | 6.3% | – | |
| – | -4.3% | -4.7% | -6.5% | -7.7% | – | – | – | – | – | – | – | |
| 63.2% | 4.2% | 1.6% | 4.1% | 80.0% | 95.4% | 174.9% | 304.5% | 379.2% | 426.3% | 244.1% | 507.3% | |
| 63.2% | 4.2% | 1.6% | 4.1% | 80.0% | 95.4% | 174.9% | 304.5% | 379.2% | 426.3% | 244.1% | 507.3% | |
| 1.1% | – | – | 0.1% | 0.1% | – | 0.4% | 0.1% | 0.1% | – | – | – | |
| 34.1% | 0.8% | 0.0% | 0.0% | 0.1% | – | 0.6% | 0.3% | 0.2% | 17.5% | 0.4% | 0.5% | |
| 36.8% | 95.8% | 98.4% | 95.9% | 20.0% | 4.6% | -74.9% | -204.5% | -279.2% | -326.3% | -144.1% | -407.3% | |
| -51.4% | -206.4% | -180.1% | -437.8% | -612.5% | -761.8% | -1,065.0% | -1,059.4% | -1,032.4% | -1,164.3% | -1,074.1% | -2,279.3% | |
| 128.7% | 372.6% | 411.4% | 821.9% | 969.4% | 1,167.9% | 1,480.5% | 1,213.4% | 1,052.8% | 1,195.2% | 1,151.7% | 2,356.5% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.